2009
DOI: 10.1007/s11094-009-0332-x
|View full text |Cite
|
Sign up to set email alerts
|

Influence of the structure of substituted benzodiazepines on their pharmacokinetic properties

Abstract: The influence of the structure of substituted benzodiazepines on their pharmacokinetic properties including the bioavailability, elimination half-life, clearance, and distribution volume in the human organism has been studied. The analysis was performed using the QSAR/QSPR method based on the Simplex representation of molecular structure. Completely adequate models capable of describing quantitatively the structure-pharmacokinetic properties relationship were obtained using the statistical methods of projectio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 15 publications
0
7
0
Order By: Relevance
“…Indeed, computational models are well established, and successfully/extensively used tools, and especially so for drug development [ 44 ]. They have already been applied to classical and designer benzodiazepines [ 45 , 46 ] and other NPS classes (e.g., synthetic cannabinoids [ 47 , 48 , 49 ], opioids [ 50 , 51 ], hallucinogenic phenylalkylamines [ 52 ], and tryptamines [ 53 ] and phenethylamines [ 54 , 55 ].…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, computational models are well established, and successfully/extensively used tools, and especially so for drug development [ 44 ]. They have already been applied to classical and designer benzodiazepines [ 45 , 46 ] and other NPS classes (e.g., synthetic cannabinoids [ 47 , 48 , 49 ], opioids [ 50 , 51 ], hallucinogenic phenylalkylamines [ 52 ], and tryptamines [ 53 ] and phenethylamines [ 54 , 55 ].…”
Section: Introductionmentioning
confidence: 99%
“…Systematic in vivo and in vitro work has also been carried out to investigate the structural characteristics that relate to pharmacological activity. From these studies estimations of activity of novel 1,4–benzodiazepines (Figure A) can be estimated for half‐life (t½), volume of distribution (V D ), bioavailability (F) as well as the potential toxicity of benzodiazepines, showing that hydrazone fragments, primary amines and saturated heterocyclic ring systems lead to increases in toxicity . The biological activity of benzodiazepines was initially studied by Hester who determined the effects of substituents on the biological activity.…”
Section: Prediction Of the Pharmacological Toxicological And Pharmamentioning
confidence: 99%
“…4.Why, during the configuration of isomerization, does the enantiomer not always pass through an achiral boundary? Antiviral activity, antimicrobial activity and antitumor activity Pharmacokinetic Parameter [25], [41][42][43][44][45] Affinity for different biological targets [46][47][48][49][50][51][52][53] Different types of toxicity [44], [54][55][56][57][58][59][60][61][62][63][64][65]…”
Section: The Methodology Of Sirmsmentioning
confidence: 99%
“…A number of our works (see Table 1 ) are devoted to solving these problems on the basis of SiRMS. In particular, [ 42 , 43 ] discuss the influence of structure on the pharmacokinetic properties of 1,4 - benzodiazepine tranquilizers.…”
Section: Qsar Models Based On Simplex Descriptorsmentioning
confidence: 99%
See 1 more Smart Citation